Iovance Biotherapeutics Inc (IOVA) Volatility Spurs A Quest For Clarity
The Vanguard Group, Inc. recently announced the acquisition of new stake in Iovance Biotherapeutics Inc (NASDAQ:IOVA). The institutional investor has increased its shareholding in the Healthcare company by 8.48% to 21.74 million shares with purchase of 1.7 million shares. This fresh investment now brings its stake to 8.77% valued currently at $83.05 million. In addition, […]
Iovance Biotherapeutics Inc (IOVA): Street Finally Waking Up
With over 4.89 million Iovance Biotherapeutics Inc (IOVA) shares trading Friday and a closing price of $5.79 on the day, the dollar volume was approximately $28.33 million. The shares have shown a negative half year performance of -24.71% and its price on 11/24/23 gained nearly 7.32%. Currently, there are 255.92M common shares owned by the […]
Why Should You Put Iovance Biotherapeutics Inc (NASDAQ: IOVA) On Your Portfolio?
The Vanguard Group, Inc. recently announced the acquisition of new stake in Iovance Biotherapeutics Inc (NASDAQ:IOVA). The institutional investor has increased its shareholding in the Healthcare company by 8.48% to 21.74 million shares with purchase of 1.7 million shares. This fresh investment now brings its stake to 8.77% valued currently at $83.05 million. In addition, […]
